alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › multi-target

multi-target

5 studies tagged multi-target, dated 2013-02-18 to 2026-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Rethinking Alzheimer's Disease Therapy: From Amyloid-Centric Approaches to Multi-Target Phytochemical Strategies 2026-07-01
  2. Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? 2023-06-02
  3. Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation 2022-09-15

Studies

5 studies carry this tag.

Date range

2013 to 2026

Top journals

  • Chemical science 1
  • Frontiers in pharmacology 1
  • Journal of neurochemistry 1
  • Journal of personalized medicine 1
  • PloS one 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Rethinking Alzheimer's Disease Therapy: From Amyloid-Centric Approaches to Multi-Target Phytochemical Strategies

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of neurochemistry 2026-07-01 Treatments

    Alzheimer's disease (AD) is the leading cause of dementia, characterized by irreversible neuronal loss and progressive cognitive decline.

  2. Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in pharmacology 2023-06-02 Treatments

    Despite extensive research, no disease-modifying therapeutic option, able to prevent, cure or halt the progression of Alzheimer's disease [AD], is currently available.

  3. Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of personalized medicine 2022-09-15 Treatments

    Alzheimer's disease (AD) is a neurodegenerative disease characterized by a tangle-shaped accumulation of beta-amyloid peptide fragments and Tau protein in brain neurons.

  4. Antimicrobial α-defensins as multi-target inhibitors against amyloid formation and microbial infection

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Chemical science 2021-05-28 Treatments

    Amyloid aggregation and microbial infection are considered as pathological risk factors for developing amyloid diseases, including Alzheimer's disease (AD), type II diabetes (T2D), Parkinson's disease (PD), and medullary thyroid carcinoma (MTC).

  5. Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. PloS one 2013-02-18 Treatments

    Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior.

All topic tags with their study counts